Results 101 to 110 of about 4,243 (197)

Paradoxical Alopecia Areata Induced by IL‐17 and IL‐23 Inhibitors: A Systematic Review

JEADV Clinical Practice, EarlyView.
This systematic review identifies consistent clinical patterns of alopecia areata associated with IL‐17 and IL‐23 inhibitors, most frequently involving secukinumab and ustekinumab. Disease severity varied widely, and management often required biologic discontinuation or therapeutic switching.
Isabella Kamholtz, Simonetta I. Gaumond, Joaquin J. Jimenez   +2 more
wiley   +1 more source

Dynamic tail amine interactions drive isoform selectivity for potent human neuronal nitric oxide synthase inhibitors. [PDF]

Med Chem Res
Awasthi A, Kang KM, Silverman RB.
europepmc   +1 more source

Metabolic Dysfunction‐Associated Steatotic Liver Disease and Obesity: Pathogenesis, Diagnostics, Risk Stratification, and Therapeutic Approach

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) has emerged as the most prevalent chronic liver disease worldwide, closely linked to the global rising incidence of obesity and metabolic syndrome. This review synthesizes current evidence on the pathogenesis, gut–liver axis, and multidisciplinary management of MASLD within the ...
Beom Kyung Kim
wiley   +1 more source

Rapid and Esthetic Wound Healing in Surgery by Applying a Powdered Mixture of Mannose and Calcium Propionate. [PDF]

Aesthetic Plast Surg
Ciucanu CI, Raţiu S, Olariu S, Ciucanu I.   +3 more
europepmc   +1 more source

Comparative Assessment of 532/1064‐nm KTP/Nd: YAG and 595‐nm Pulsed Dye Laser for Cutaneous Vascular Lesions: A Prospective Split‐Site Study

Lasers in Surgery and Medicine, EarlyView.
ABSTRACT Objectives This exploratory pilot study aims to characterize effective laser settings and evaluate the clinical outcomes and tolerability of a dual‐wavelength 532/1064‐nm KTP/Nd: YAG laser system compared to a 595‐nm pulsed dye laser with cryogen spray cooling, across multiple vascular indications, including port‐wine capillary malformations ...
Olamide Sonuga Finney, Feben Messele, Karishma S. Shah, Cameron Zachary, Sungat Grewal, Kristen M. Kelly   +5 more
wiley   +1 more source

Proteomics of Nitrotyrosine: Integrating Mass Spectrometry and Immunodetection in Redox‐Driven Pathology

Mass Spectrometry Reviews, EarlyView.
ABSTRACT Nitrooxidative stress, driven by excess reactive nitrogen species like peroxynitrite, contributes to the pathogenesis of many chronic diseases. Among its molecular footprints, 3‐nitrotyrosine (3NT) has emerged as a biologically relevant marker of protein nitration.
Brîndușa Alina Petre
wiley   +1 more source

Electron Affinity of Actinide (IV) Carboxylate Complexes From MN12-L Density-Functional Calculations and Explainable Machine Learning. [PDF]

J Comput Chem
Khairbek AA, Badawi MAA, Puchta R, Saleh DI, Mahmoud SF, Thomas R.   +5 more
europepmc   +1 more source

Repurposing antimicrobial agents for neuroprotection: Mechanisms, clinical potential, and challenges

Neuroprotection, EarlyView.
Antimicrobial agents exert neuroprotective effects through modulation of interconnected pathways. Tetracyclines, macrolides, antimalarial agents, sulfones, and antiparasitic agents suppress neuroinflammation, oxidative stress, and apoptosis while preserving mitochondrial function and neurotransmission.
Mohammad Amin Manavi, Mohammadreza Salehi, Razieh Mohammad Jafari, Ramin Goudarzi, Saman Khosravi, Ahmad Reza Dehpour   +5 more
wiley   +1 more source

The Intricate Mechanism of Nitric Oxide Synthase. [PDF]

J Comput Chem
Siegbahn PEM.
europepmc   +1 more source

Efficacy of Exhalation Delivery System With Fluticasone in Chronic Rhinosinusitis With Versus Without Polyps

Otolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective To evaluate whether treatment responses to the exhalation delivery system with fluticasone (EDS‐FLU; XHANCE®) differ between patients with CRS with nasal polyps (CRSwNP) and patients without nasal polyps (CRSsNP). Study Design Post hoc analysis of the ReOpen clinical trials conducted between November 2018 and November 2021 for a 24 ...
Rodney J. Schlosser, Nithin D. Adappa, Rakesh K. Chandra, Greg E. Davis, Mahboobeh Mahdavinia, John Messina, Zara M. Patel, Anju T. Peters, Raj Sindwani, Zachary M. Soler, Andrew A. White, Sarah K. Wise, James N. Palmer   +12 more
wiley   +1 more source